Imigran Radis (Sumatriptan)

Sumatriptan acts as an agonist at serotonin 5‑HT1B and 5‑HT1D receptors located on cranial blood vessels and sensory nerve endings. This activation causes vasoconstriction of dilated intracranial vessels and blocks the release of inflammatory neuropeptides, effectively aborting a migraine attack.

The specific dose of Imigran Radis is determined by the prescribing healthcare professional based on the individual’s clinical condition, response to therapy, and any relevant medical history. Patients should follow the prescriber’s instructions and not alter the dose without medical advice.

Safety data for sumatriptan in pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their prescriber.

To place an order, submit an enquiry on the Imigran Radis product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imigran Radis belongs to the triptan class, which provides targeted serotonin receptor activation and rapid migraine relief. Compared with non‑specific analgesics such as NSAIDs, triptans like sumatriptan generally achieve faster and more complete headache resolution but require careful cardiovascular assessment before use.

Imigran Radis tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Imigran Radis is taken orally as a whole tablet with a glass of water. It should be swallowed whole and not chewed or crushed. For optimal effect, the tablet is usually taken at the first sign of a migraine attack, as directed by the prescriber.

Serious adverse events include coronary vasospasm, which can cause chest pain, severe allergic reactions such as anaphylaxis, and serotonin syndrome when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience any of these symptoms.

Imigran Radis is contraindicated in patients with uncontrolled coronary artery disease, a history of myocardial infarction, severe peripheral vascular disease, uncontrolled hypertension, or known hypersensitivity to sumatriptan or any tablet excipients. It should also be avoided in individuals taking MAO inhibitors within the past two weeks.